Henry E. Pelish - Dec 16, 2024 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
Chief Scientific Officer
Signature
/s/ Nathan N. McConarty, attorney-in-fact
Stock symbol
NUVL
Transactions as of
Dec 16, 2024
Transactions value $
$7,759
Form type
4
Date filed
12/18/2024, 04:50 PM
Previous filing
Sep 18, 2024
Next filing
Jan 8, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVL Class A Common Stock Options Exercise $3.84K +5.91K +17.76% $0.65 39.2K Dec 16, 2024 Direct
transaction NUVL Class A Common Stock Options Exercise $3.92K +4.5K +11.48% $0.87 43.7K Dec 16, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -5.91K -100% $0.00 0 Dec 16, 2024 Class A Common Stock 5.91K $0.65 Direct F1
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -4.5K -46.74% $0.00 5.13K Dec 16, 2024 Class A Common Stock 4.5K $0.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option are fully vested.